LifeStance Health Group, Inc. (LFST) has a consensus analyst rating of Buy, based on 11 analysts covering the stock. Of those, 10 recommend buying, 1 recommend holding, and 0 recommend selling.
The analyst consensus price target for LFST is $9.30, representing a +42.9% upside from the current price of $6.51. Price targets range from a low of $8.00 to a high of $11.00.
